Thermo Igniter 12X

by GNC Pro Performance · capsule · 14 pre-training packs

  • On the market (NIH)
  • DSLD label 27420
  • Serving 1 red capsule

Thermo Igniter 12X by GNC Pro Performance lists 4 ingredients, 1 with an amount per serving of 1 red capsule, such as 20 mg of niacin; 3 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on February 26, 2014.

What is in Thermo Igniter 12X?

Each row as the label prints it, per serving of 1 red capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Thermo Igniter 12X: Supplement Facts rows against the market (DSLD label 27420, January 2026 release)
IngredientAmount% DVAmong products listing it
Niacin20 mg100%Niacin in Thermo Igniter 12X against 12,413 products20 mg per serving; the middle half of products list 13.2 mg to 48 mg, the median 20 mg.DV 16 mgUL 35 mg20 mg

46% of 12,413 products listing niacin give more (median 20 mg).

Proprietary Thermogenic Blend243.34 mg
Caffeine Anhydrousin the blend, no amount given
Capsimax(TM) Capsicum Fruit Extractin the blend, no amount given
Black Pepper extractin the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 27420 (entered February 26, 2014), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 3 ingredients sit inside a blend, so their amounts cannot be compared.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
DIRECTIONS: As a dietary supplement, consume 1 Pre-Training Pack before workout begins, 1 serving of 100% Whey Protein mid-morning or afternoon and 1 Nighttime Strength & Support Pack before bedtime.

Source: label statements in DSLD label 27420.

What else is on the label?

Other ingredients: Cellulose, Gelatin, Titanium Dioxide, Artificial Colors.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): NITRO-FACTOR 34G(TM).

How many labels does Thermo Igniter 12X have?

One label is on file, entered on February 26, 2014.

  1. Label 27420 (current) Entered February 26, 2014 · on the market · 14 pre-training packs

DSLD also links this label to: Muscle Fatigue Buffer (bundle set), Creatine Strength Support (bundle set), Nighttime Restore (bundle set), 100% Whey Protein Chocolate Supreme (bundle set).

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names GNC (manufacturer). All GNC Pro Performance products.

Where next?